We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIVI
2501
DELISTED
Civitas Resources
CIVI
$216K ﹤0.01%
+55
New +$224K
XOMA
2502
DELISTED
Xoma
XOMA
$216K ﹤0.01%
+2,980
New +$222K
ARTX
2503
DELISTED
Arotech Corporation
ARTX
$215K ﹤0.01%
+143,400
New +$181K
SGNT
2504
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$214K ﹤0.01%
+10,200
New +$182K
KFRC icon
2505
Kforce
KFRC
$1.03B
$213K ﹤0.01%
+14,600
New +$214K
BDMS
2506
DELISTED
BIRNER DENTAL MGMT SVCS INC
BDMS
$213K ﹤0.01%
+11,900
New +$213K
MPU icon
2507
Mega Matrix
MPU
$15.5M
$212K ﹤0.01%
+54,500
New +$214K
MTSL
2508
DELISTED
MER TELEMANAGEMENT SOLUTNS LTD
MTSL
$212K ﹤0.01%
+137,000
New +$212K
ESBF
2509
DELISTED
E S B FINL CORP
ESBF
$211K ﹤0.01%
+17,432
New +$208K
GEVO icon
2510
Gevo
GEVO
$365M
$208K ﹤0.01%
+17
New +$189K
CRTN
2511
DELISTED
Cartesian, Inc.
CRTN
$208K ﹤0.01%
+68,480
New +$203K
CBNJ
2512
DELISTED
CAPE BANCORP, INC COM
CBNJ
$207K ﹤0.01%
+21,800
New +$200K
KCLI
2513
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
$207K ﹤0.01%
+5,400
New +$201K
UONE icon
2514
Urban One Class A
UONE
$22.6M
$206K ﹤0.01%
+8,350
New +$170K
UONEK icon
2515
Urban One Class D
UONEK
$22.6M
$204K ﹤0.01%
+8,780
New +$177K
ANGO icon
2516
AngioDynamics
ANGO
$591M
$202K ﹤0.01%
+17,946
New +$191K
CW icon
2517
Curtiss-Wright
CW
$26.5B
$200K ﹤0.01%
+5,400
New +$187K
VATE icon
2518
INNOVATE Corp
VATE
$117M
$199K ﹤0.01%
+1,670
New +$198K
EMITF
2519
DELISTED
Elbit Imaging Ltd
EMITF
$197K ﹤0.01%
+1,527
New +$198K
TPI
2520
DELISTED
TIANYIN PHARMACEUTICAL
TPI
$196K ﹤0.01%
+398,300
New +$234K
VRS
2521
DELISTED
VERSO CORP COM STK (DE)
VRS
$196K ﹤0.01%
+170,200
New +$198K
MEA
2522
DELISTED
METALICO INC
MEA
$194K ﹤0.01%
+161,800
New +$242K
GAU
2523
Galiano Gold
GAU
$468M
$193K ﹤0.01%
+91,900
New +$230K
TGA
2524
DELISTED
Transglobe Energy Corp
TGA
$193K ﹤0.01%
+31,200
New +$231K
PIKE
2525
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
$193K ﹤0.01%
+15,700
New +$211K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.